These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 116387)

  • 1. Anti-platelet effects of long-term treatment with gliclazide in diabetic patients.
    Ponari O; Civardi E; Megha S; Pini M; Portioli D; Dettori AG
    Thromb Res; 1979; 16(1-2):191-203. PubMed ID: 116387
    [No Abstract]   [Full Text] [Related]  

  • 2. Sulfonylureas and platelet function.
    Klaff LJ; Kernoff L; Vinik AI; Jackson WP; Jacobs P
    Am J Med; 1981 Mar; 70(3):627-30. PubMed ID: 6782875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of gliclazide on platelet behavior].
    Verry M; Dechavanne M; Desnoyers P; Stoltz JF; Vainer H
    Nouv Presse Med; 1974 Oct; 3(33):2099-100. PubMed ID: 4471584
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect on platelet adhesiveness in diabetics after long-term treatment with a new oral hypoglycaemic agent, gliclazide.
    Rubinjoni Z; Turk Z; Coce F; Mustovic D; Maitre D; Skrabalo Z
    Curr Med Res Opin; 1978; 5(8):625-31. PubMed ID: 361347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
    Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of gliclazide and glibenclamide treatment in non-insulin-dependent diabetes.
    Baba S; Nakagawa S; Takebe K; Goto Y; Maezawa H; Takeda R; Sakamoto N; Fukui I
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():693-706. PubMed ID: 6440313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of glycaemic control, metformin and gliclazide on platelet density and aggregability in recently diagnosed type 2 (non-insulin-dependent) diabetic patients.
    Collier A; Watson HH; Patrick AW; Ludlam CA; Clarke BF
    Diabete Metab; 1989; 15(6):420-5. PubMed ID: 2534084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of gliclazide on platelet function in patients with diabetes mellitus.
    Violi F; De Mattia GC; Alessandri C; Perrone A; Vezza E
    Curr Med Res Opin; 1982; 8(3):200-3. PubMed ID: 7128193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Medium term effect (3 months) of hypoglycemic sulfamide treatment (gliclazide) on insulin secretion of the non-insulin dependent diabetic].
    Brogard JM; Pinget M; Leconte A; Dorner M
    Rev Med Interne; 1982 Dec; 3(4):379-87. PubMed ID: 6761818
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibitory action of gliclazide on platelet functions.
    Mizuno A; Yano M; Isobe J; Shima K
    Diabetes Res Clin Pract; 1989 Aug; 7(2):141-7. PubMed ID: 2505994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Efficacy of gliclazide in short and long-term therapy of older persons with noninsulin-dependent diabetes].
    Djurić DS; Djordjević PB; Micić D; Dragasević M
    Srp Arh Celok Lek; 1981 Nov; 109(11):1503-9. PubMed ID: 7051354
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of gliclazide in diabetes: a comparison with tolbutamide.
    Berber MJ; Tomkin GH
    Ir J Med Sci; 1982 Feb; 151(2):46-9. PubMed ID: 7047455
    [No Abstract]   [Full Text] [Related]  

  • 13. Preventive and therapeutic effects of gliclazide on diabetic retinopathy: comparison with glibenclamide treatment.
    Minami N; Ikeda Y; Abe M
    Tohoku J Exp Med; 1983 Dec; 141 Suppl():707-11. PubMed ID: 6440314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 15. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemobiological activity of gliclazide in diabetes mellitus.
    Ziegler O; Drouin P
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S83-9. PubMed ID: 1794271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenosine diphosphate-induced platelet aggregation of hospitalized men.
    Davis JW; Yue KT; Phillips PE; McField JR
    Scand J Haematol; 1974; 13(1):17-23. PubMed ID: 4411871
    [No Abstract]   [Full Text] [Related]  

  • 18. [A new therapeutic approach to diabetes. Long-term survey].
    Charbonnel B
    Sem Hop Ther; 1977 Nov; 53(9):460-5. PubMed ID: 341321
    [No Abstract]   [Full Text] [Related]  

  • 19. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)].
    Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M
    Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345
    [No Abstract]   [Full Text] [Related]  

  • 20. Lack of effect of gliclazide on platelet aggregation in insulin-treated and non-insulin-treated diabetes: a two-year controlled study.
    Larkins RG; Jerums G; Taft JL; Godfrey H; Smith IL; Martin TJ
    Diabetes Res Clin Pract; 1988 Jan; 4(2):81-7. PubMed ID: 3125029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.